n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, August 10th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Integrated Ventures, Inc. (INTV)

InvestorsHub and TradingView reported on Integrated Ventures, Inc. (INTV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Integrated Ventures, Inc. is a holding company listed on the OTC Markets Group’s OTCQB. The Company acquires, invests in, and also operates in private companies that have an experienced management team, strong operating histories, minimum debt, high growth potential and tangible assets, designed to mitigate investor risk. Integrated Ventures has its head office in Huntingdon Valley, Pennsylvania. The Company was previously known as EMS Find, Inc. It changed its corporate name to Integrated Ventures, Inc. in July of 2017.

The Company involves chiefly with companies in the health care, medicinal cannabis, mobile technologies, transportation, as well as consumer goods markets. It is concentrating on implementing innovative business strategies and on creating liquidity via asset based infrastructure.

Technology markets services consist of Website Design & Development; On Demand Mobile Platforms; eCommerce Solutions; Cyber Security; and Social Media & Marketing. Healthcare markets services consist of Ride Share Transportation; Claims Management; Systems Configuration & Integration; Mobile Diagnostic Testing; and Medical Devices Design & Distribution.

Financial markets services include Convertible Debt Funding Solutions; Business Restructuring; Mergers & Acquisitions (M&As); and Going Public Consulting. Consumer Goods services include Distribution & Manufacturing Operations; Design, Sourcing & Manufacturing; and Branding & Marketing Consulting.

Additionally, Integrated Ventures is focusing on supporting and improving operations, on securing and infusing growth capital, and on maintaining and expanding a market presence in its niche sectors. This is while continually enhancing this process through numerous initiatives.

Integrated Ventures provides smaller, middle market private companies with capitalization and liquidity strategy. The intention of this business strategy is to provide shareholders with access to innovative opportunities with the potential for considerable upside while lessening risk via diversification. The Company’s portfolio includes 888.RIDE.SHARE; EMS Find; Wireless Industry Corporation, and Agropharmacia.

Integrated Ventures completed the first Inventory Financing Round to Viva Entertainment Group, Inc. on July 3, 2017, in the amount of $50,000.00. The proceeds are to be used to finance the purchases of OTT equipment (set up boxes), to finance marketing initiatives, and to finance software development and technical upgrades for the VivaLiveTV Platform.

Integrated Ventures, Inc. (INTV), closed Thursday's trading session at $0.00245, down 2.00%, on 8,709,203 volume with 40 trades. The average volume for the last 60 days is 2,156,338 and the stock's 52-week low/high is $0.0008/$0.197.

Elbit Vision Systems Ltd. (EVSNF)

Marketbeat, Zacks, and Stockpalooza reported on Elbit Vision Systems Ltd. (EVSNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1991, Elbit Vision Systems Ltd. is a pioneer in the science of camera-based automatic vision inspection for textile fabrics and technical webs. The Company’s systems are used by more than 800 customers, many of these customers are foremost international companies. Elbit Vision Systems’ shares trade on the OTC Markets Group’s OTCQB. The Company is based in Caesarea, Israel, and has its North American office in Greenville, South Carolina.

Since 1992, Elbit Vision Systems is a worldwide leader in the field of Automatic Optical Inspection (AOI), applied in the production and quality control of fabrics and web. The targeting of the Company’s progressive computerized vision technology is at modernizing production and quality control processes.

Elbit Vision Systems offers an extensive portfolio of automatic state-of-the-art Visual Inspection Systems for in-line and off-line applications. In addition, it offers process monitoring systems used to improve product quality, safety, and also to increase production efficiency.

The Company’s systems perform operations, automatically and in real time. These operations comprise: detecting and categorizing spinning, weaving, dyeing, finishing and other web defects; as well as analyzing the shade consistency of fabrics.

Elbit Vision Systems products include IQ-TEX 4; iBar; SVA, and OCC. IQ-TEX 4 is a fully integrated image acquisition & processing system. It is constructed on the Company’s proprietary Smart Vision Camera (SVC) platform.

Moreover, iBar is the first truly automated, in-line, product and process monitoring solution for fabric formation machines. The design of, and the building of iBar was specifically for the worst environments imaginable in the contemporary, high speed textile industry.
SVA is a new generation in shade monitoring technology developed by Elbit Vision Systems. SVA is a compact, robust tool, which monitors shade variations in almost any process where color is vital.

The Company’s OCC (Optimization & Cut Control System) Cut Optimization software module optimizes the fabric yield per class (e.g. A; B; C, and so on) according to a group of constraints when cutting an "IQ-TEX Inspected" roll of fabric into smaller rolls.

Yesterday, Elbit Vision Systems presented its consolidated financial results for the quarter ending June 30, 2017. Q2 2017 highlights include Revenue of $2.3 million and Gross and Operating Margins at 55.9 percent and 18.7 percent, respectively.

Moreover, Q2 2017 highlights include Net Income of $396,000. This represents 17.4 percent of Revenues. Also, Shareholders’ Equity reached $6.7 million. Cash and Equivalents was $4.4 million.

Elbit Vision Systems has a global Sales and Service network. This network is to support markets and hundreds of inspection systems already installed in Asia, Europe, Africa, Australia and the Americas.

Elbit Vision Systems Ltd. (EVSNF), closed Thursday's trading session at $3.30, down 2.65%, on 15,325 volume with 27 trades. The average volume for the last 60 days is 10,074 and the stock's 52-week low/high is $2.66/$4.50.

Northwest Biotherapeutics, Inc. (NWBO)

StockPicksNYC, Streetwise Reports, Wealthpire, StreetInsider, OTCPicks, FeedBlitz, AllPennyStocks, The Street, Marketbeat.com, Promotion Stock Secrets, RedChip, Wall Street Corner, BUYINS.NET, INO Market Report, WealthMakers, PureActionStocks, Pennybuster, InvestorPlace, CoolPennyStocks, BullRally, and SmallCapVoice reported earlier on Northwest Biotherapeutics, Inc. (NWBO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Northwest Biotherapeutics, Inc. is a biotechnology enterprise developing DCVax® personalized immune therapies for solid tumor cancers. In the U.S. and Europe, the Company’s emphasis is on developing personalized immunotherapy products, on a cost-effective basis, designed to treat cancers more effectively than existing treatments. This is without toxicities of the kind associated with chemotherapies. Northwest Biotherapeutics is based in Bethesda, Maryland.

The Company has a comprehensive platform technology for DCVax dendritic cell-based vaccines. It is working to move ahead with multiple clinical programs, involving DCVax-L and DCVax-Direct.

Northwest is pursuing completion of the present Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer and pursuing Phase II combination trials of DCVax-L and checkpoint inhibitor drugs. This includes the Phase II trial of DCVax-L and Pembrolizumab (Keytruda) for colon cancer, which was previously announced.

Northwest Biotherapeutics’ lead program is a 331-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). This trial has completed its enrollment.

Additionally, Northwest Biotherapeutics earlier received clearance from the Food and Drug Administration (FDA) for a 612-patient Phase III trial in prostate cancer. It received approval in Germany of a five-year Hospital Exemption for the treatment of all gliomas (primary brain cancers) outside the clinical trial.

Northwest Biotherapeutics provided a further update in February 2017 concerning its Phase III trial of DCVax®-L for Glioblastoma multiforme (GBM) brain cancer. It announced that the partial clinical hold on the Trial was lifted by the FDA, and that the Trial accumulated enough events toward the progression-free survival (PFS) endpoint, but not yet for the overall survival (OS) endpoint.

Northwest Biotherapeutics is also pursuing a Phase I/II trial with DCVax-Direct for all kinds of inoperable solid tumor cancers.  It has completed the 40-patient Phase I portion of the trial, and is preparing the Phase II portion. Northwest Biotherapeutics earlier conducted a Phase I/II trial with DCVax-L for metastatic ovarian cancer in conjunction with the University of Pennsylvania.

Northwest Biotherapeutics, Inc. (NWBO), closed Thursday's trading session at $0.188, down 0.53%, on 683,211 volume with 104 trades. The average volume for the last 60 days is 2,261,199 and the stock's 52-week low/high is $0.14/$0.50.

Pura Naturals, Inc. (PNAT)

OTC Markets and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean via its pioneering BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology, which absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. The Company centers on plant-based products made from renewable resources with no petroleum by-products. Pura Naturals is headquartered in Lake Forest, California.

Pura Naturals’ product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies. Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Its household cleaning product delivers an innovative soap infusion. The ground-breaking foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

The Company also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA).

Pura Naturals’ Marine products are reusable and absorb up to 14 times their weight. Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

Pura Naturals has its Pura Marine division, which concentrates on developing solutions employing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors.

Pura Naturals, utilizing its BeBetterFoam®, designed an innovative filtration device for closed orifices and scuppers. The Company has now filed a patent application with the United States Patent and Trademark Office (USPTO). The new "Scupper Plug" product is mainly used for the marine industry. However, its has numerous other applications. The Scupper Plug sells under the Pura Marine division of Pura Naturals. The Scupper Plug permits water to freely flow through any orifice, but remediates and collects the oils, which incline to create problems in drainage situations.

Pura Naturals' Board of Directors has approved the acquisition of the foam formulas and related intellectual property (IP) rights from Advanced Innovative Recovery Technologies, Inc. (AIRTech) under the license agreement between the parties. The transaction (also approved by the Board of AIRTech) jettisons greater than $800,000 in existing Pura Naturals debt obligations in exchange for stock. Pura Naturals’ IP portfolio comprises one patent pending and one patent in the application stage, six registered trademarks, and eight pending trademarks.

The Company also has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner. The design of it is to cut through very greasy messes to leave behind only a citrus scent. The Pura Pro Bio-Degreaser recently finished beta-testing with Pura Naturals’ partners in the marine oil transport industry.

Mr. Jeff Silver, Vice President of Pura Marine said, "Our testing within the marine oil transport industry has been overwhelmingly positive. Our Bio-Degreaser cleaned some of the toughest jobs it faced in half the time it took with their current degreaser products. We believe Pura Pro Bio-Degreaser will be a disruptive technology in this market." 

Pura Naturals, Inc. (PNAT), closed Thursday's trading session at $0.649, up 8.17%, on 18,163 volume with 25 trades. The average volume for the last 60 days is 57,428 and the stock's 52-week low/high is $0.1486/$3.70.

American Cannabis Company, Inc. (AMMJ)

Wealth Insider Alert, Market Intelligence Central, Wall Street Daily, The Street, Marketbeat, Promotion Stock Secrets, CFN Media Group, Cannabis Financial Network News, Stock News Now, and TheOTCInvestor reported earlier on American Cannabis Company, Inc. (AMMJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Cannabis Company, Inc. is a full-service Business-to-Business (B2B) consulting solutions provider. In addition, the Company is a seller of ancillary products to the cannabis industry. American Cannabis provides end-to-end solutions to existing and ambitious participants in the cannabis industry. Listed on the OTCQB, American Cannabis Company has its corporate headquarters in Denver, Colorado.

Through Company supports its clients from concept to creation, commercialization and continuing operations.  American Cannabis Company provides complete consulting management and products solutions to the regulated cannabis markets. It uses its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure, and establish operational best practices.

American Cannabis Company has its proprietary product called SoHum Living Soils™. SoHum Living Soils™ is a proprietary "just add water" growing medium. It contains 100 percent natural ingredients. SoHum Living Soils® won the 2017 High Times STASH award for "Best Potting Mix."

SoHum Living Soils™ provides the plant a comprehensive buffet of macro/micro nutrients to attain genetic optimization of the cannabis plant. Furthermore, the Company owns The Cultivation Cube™, and The High Density Cultivation System™ - proprietary cultivation products.

Regarding Products, American Cannabis provides a complete organic grow system, retail solutions (the Satchel™), grow components, and group purchasing discounts for supplies. The Satchel is a child-proof, tamper-proof vessel for dispensaries. The Satchel™ may be used by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each state's legislation.

Pertaining to Consulting, American Cannabis provides application support, business planning, site selection, and regulatory compliance, among other services. Concerning Management, the Company provides yield analysis, staffing, business coaching, and staff training and education, and more.

Last week, American Cannabis Company announced that it secured its third client in Arkansas. This client has initially retained the Company to provide pre-licensing solutions for its project. American Cannabis Company will work with the client on strong financial pro-forma modeling, the creation of a custom business plan, facility conceptual design work, and with the completion of the state application. American Cannabis Company expects to take advantage of this contract to secure additional revenues by way of long-term consulting agreements and potential future sales of ancillary products.

American Cannabis Company, Inc. (AMMJ), closed Thursday's trading session at $0.74, down 2.63%, on 231,824 volume with 133 trades. The average volume for the last 60 days is 195,844 and the stock's 52-week low/high is $0.09/$2.10.

graphic

The QualityStocks
Company Corner

graphic
graphic

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0335, up 12.04%, on 1,935,366 volume with 61 trades. The stock’s average daily volume over the past 60 days is 89,518, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. and MoneyTrac Technology Enter the Multi-Billion Dollar CBD Market through their Agreement with H Smart, Inc.

Marijuana Company of America Completes $250,000 Investment in MoneyTrac Technology

Global Payout's Majority Owned Subsidiary, MoneyTrac Technology, Inc., Completes Joint Venture Agreement with Compliance Financial Network Corp (CFN)

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.045, up 18.42%, on 30,641,983 volume with 1,141 trades. The stock’s average daily volume over the past 60 days is 12,411,241, and its 52-week low/high is $0.0075/$0.142.

CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article that examines SinglePoint Inc.'s (SING) purchase of WeedCoin from First Bitcoin Capital Inc. and the emerging role cryptocurrencies are playing within the burgeoning cannabis industry. Cryptocurrencies have become increasingly popular over the past several years. Since its launch in 2009, Bitcoin has amassed a market capitalization of more than $54 billion. Hundreds of other cryptocurrencies followed in its footsteps with several others surpassing the $1 billion mark when it comes to market capitalization. Many of these currencies are leveraging newer blockchain technologies or targeting unique end markets to achieve growth.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Invests in WeedCoin Cryptocurrency -- CFN Media

NetworkNewsWire Announces Publication Discussing Bitcoin's Potential to Fill the Void of Federal Banking Resources in the Legal Marijuana Industry

SinglePoint Inc. Announces Purchase of $Weed as Money from Joint Venture Partner First Bitcoin Capital

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.38, off by 2.54%, on 238,319 volume with 69 trades. The stock’s average daily volume over the past 60 days is 72,458 and its 52-week low/high is $0.0913/$0.699.

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP) CEO Chris Bunka was interviewed on the Uptick Network Stock Day Radio Show with host Everett Jolly. Mr. Bunka updates the Uptick Network on the overall accomplishments that have presented itself in the past 3 months. Mr. Bunka further discusses the outlook for shareholders, their expectations for the company’s profitability and where the company is at in this progress. R&D could open the NSAID and Nicotine markets to Lexaria and with significant increase in corporate revenues, additional expansion is ahead.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

CEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future Progress

Lexaria Bioscience Corp. Engages NetworkNewsWire for Corporate Communications Solutions

NetworkNewsWire Announces Publication Highlighting the Operations of Several Public Cannabis-Biotech Companies

HighCom Global Security, Inc. (HCGS)

The QualityStocks Daily Newsletter would like to spotlight HighCom Global Security, Inc. (HCGS). Today, HighCom Global Security, Inc. closed trading at $0.013, up 116.67%, on 75,079 volume with 9 trades. The stock’s average daily volume over the past 60 days is 3,364 and its 52-week low/high is $0.005/$0.10.

HighCom Global Security, Inc. (HCGS) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

BlastGard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

HighCom Global Security, Inc. Blog

HighCom Global Security, Inc. News:

BlastGard International, Inc. Announces Name and Symbol Change to HighCom Global Security, Inc. (HCGS), Rebranding Initiative to Reflect Expanded Growth Strategy

BlastGard International, Inc. (BLGA) Engages NetworkNewsWire for Corporate Communications Solutions

BlastGard International Inc. (BLGA) is “One to Watch”

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.06, up 13.21%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 9,425 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

Algae Dynamics Corp Announces Engagement of Atlanta-Based Broker Dealer Carter, Terry & Company

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(HCGS) +116.67%

2.

Wolf of Penny Stocks
(INLX) +44.23%

3.

MarketBeat
(GLRI) +24.38%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251